No Detail Found!

Correlation of Serum Erythropoietin Levels with Di erent Stages of Diabetic Retinopathy

Author(s)
Tauseef Gul Muhammad Department of Chemical Pathology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Zujaja Hina Haroon Department of Chemical Pathology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Muhammad Younas Department of Chemical Pathology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Muhammad Usman Munir Department of Chemical Pathology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Muhammad Ahsan Mukhtar Department of Ophthalmology, Armed Forces Institute of Ophthalmology,Rawalpindi,Pakistan
Muhammad Anwar Department of Chemical Pathology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Abstract
Objective: To determine the correlation of serum erythropoietin concentration with diabetic retinopathy in patients with type 2 diabetes mellitus. Study Design: Cross-sectional study. Place and Duration of the Study: Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, from July to December 2021. Methodology: A total of 180 individuals were enrolled in the study and placed in 2 groups as group 1 have 90 cases of type 2 diabetes mellitus and group 2 having 90 age-matched healthy controls. Group 1 was further subclassi ed into proliferative diabetic retinopathy (PDR) and non-proliferative diabetic retinopathy (NPDR) subgroups by an expert ophthalmologist. Serum erythropoietin, creatinine, blood HbA1c, and haemoglobin were analysed. Correlation between stages of proliferation and serum erythropoietin, creatinine, blood HbA1c, and haemoglobin were analysed. An independent-sample student t-test was applied to compare mean Serum erythropoietin between PDR and NPDR groups. Pearson s correlation was applied among disease severity, and type of retinopathy. A p-value of d0.05 was considered signi cant. Results: The average age of participants in groups 1 and 2 was45.88±8.6 and 56.6±10.23 years, respectively. More males (n=60, 66.7%) were noted in cases compared to controls (n=42, 46.7%). serum erythropoietin concentration observed in cases (8.4±1.87 IU/L) was higher than controls (6.50±0.9).The mean serum erythropoietin concentration in PDR (9.3±51.74 IU/L) was signi cantly greater than that in NPDR (7.3±1.38 IU/L, p <0.001). The serum concentration of erythropoietin in group 1 increased linearly with the severity of the disease (r=0.103). Conclusion: Serum erythropoietin concentrations increased in uncontrolled type 2 diabetics more so in proliferative retinopathy cases, and increased with disease severity.
Publication Details
Page(s) 380-384
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Diabetic retinopathy, Proliferative diabetic retinopathy, Erythropoietin
0

Citations

0

Downloads

95

Views